
Conference Coverage
about 3 hours ago
Rare Disease Coverage Decisions Require Ongoing Evidence Reviewabout 4 hours ago
Strengthening Patient Experience Data Reliability in Payer DecisionsLatest Content

Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026

Disease Extent Linked to Complications After Deep Endometriosis Surgery

Cranberry Supplement Tied to Greater OAB Score Reductions in Pilot Trial

Acoramidis Linked to Fewer Hospitalizations Than Tafamidis in ATTR-CM

NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus

Shorts










Center on Health Equity & Access
All News

Naim Alkhouri, MD, on when to judge MASH treatment response, counseling on weight and muscle loss, primary care screening, and future trial end points.

In an insured population with advanced lung cancer, clinical trial participants had lower or similar total health care costs compared with nonparticipants.

ALLEGRO extension news shows Litfulo (ritlecitinib) delivers durable hair regrowth in severe alopecia areata after 3 years.

The planned separation would keep Aetna, CVS Caremark, and Oak Street Health together and move roughly 9000 drugstores into a new CVS Pharmacy.

The GOLD International COPD Conference will cover underdiagnosis, exacerbations, mucus, biologics, and a preview of the 2027 GOLD Report.

People with multiple sclerosis make up most of a survey linking variable-friction footwear to fewer self-reported falls.

Clinicians at an AJMC roundtable in Cleveland said Medicare's GLP-1 Bridge came late and that cost and capacity gaps persist.

Nathan Estrada, DPT, explains which patients, including those with multiple sclerosis, may benefit from footwear that adapts to gait.

Patients with Sjögren disease have 5-fold higher odds of depression, yet screening tools remain unvalidated, a new review finds.

Medicare Advantage exits, rising ACA premiums, a Medicare for America bill, and a Medicaid work rule ruling frame health policy on Election Day.






























